1. A Population Pharmacokinetic Model of (R)‐ and (S‐) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy Volunteers. (13th January 2021) Authors: Kretschmar, Melanie; Suleiman, Ahmed Abbas; Krause, Petra; Albrecht, Uwe; Stein, Raimund; Rubenwolf, Peter; Fuhr, Uwe; Taubert, Max Journal: Journal of clinical pharmacology Issue: Volume 61:Number 7(2021) Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study. Issue 1 (1st January 2015) Authors: Albrecht, Uwe; Müller, Valentina; Schneider, Berthold; Stange, Rainer Journal: BMJ open gastroenterology Issue: Volume 1:Issue 1(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi‐center trial. Issue 5 (8th March 2015) Authors: Schröder, Annette; Albrecht, Uwe; Schnitker, Jörg; Reitz, André; Stein, Raimund Journal: Neurourology and urodynamics Issue: Volume 35:Issue 5(2016:Jun.) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗